Population Pharmacokinetics and Exposure-Response Relationships of Baloxavir Marboxil in Influenza Patients at High Risk of Complications

Antzeko izenburuak

• 1536. Population Pharmacokinetic Analysis of Baloxavir Morboxil, a Cap-Dependent Endonuclease Inhibitor, in Adult and Adolescent Healthy Subjects and Influenza Patients and Exposure-Response Relationships in the Patients at High-Risk of Influenza Complications
  nork: Koshimichi, Hiroki, et al.
  Argitaratua: (2019)
• Safety, Tolerability, and Pharmacokinetics of the Novel Anti-influenza Agent Baloxavir Marboxil in Healthy Adults: Phase I Study Findings
  nork: Koshimichi, Hiroki, et al.
  Argitaratua: (2018)
• Pharmacokinetics, safety, and simulated efficacy of an influenza treatment, baloxavir marboxil, in Chinese individuals
  nork: Yanmei Liu, et al.
  Argitaratua: (2022-05-01)
• Baloxavir Marboxil in Japanese Pediatric Patients With Influenza: Safety and Clinical and Virologic Outcomes
  nork: Hirotsu, Nobuo, et al.
  Argitaratua: (2020)
• Baloxavir Marboxil 2% Granules in Japanese Children With Influenza: An Open-label Phase 3 Study
  nork: Yokoyama, Takato, et al.
  Argitaratua: (2020)